MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

The benefits of naltrexone/bupropion (Mysimba) continue to outweigh its risks, despite ongoing uncertainty about long-term ...

Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.

Drugs like Ozempic, Wegovy, and Saxenda have become hugely popular. But could they cause psychological side effects in their ...

A large majority of older Americans feel that health insurance—including Medicare—should cover anti-obesity medications, ...

"I see patients with Medicare every day who are struggling with health complications of obesity and have tried and failed to change their weight with lifestyle alone. I have to te ...

Weight loss gummies claim to burn fat, suppress hunger, and boost your metabolism to help with weight loss, but these ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

John Amos, Dr. Farhad Zangeneh, Medical Director of Endocrine, Diabetes and Osteoporosis Clinic, Dr. Dina Peralta-Reich, New York Weight Wellness Medicine Founder and Director, and Peter Maher, a ...

She also told her brother she had taken "herbal diet pills" and said "I'll see you later" as she was leaving for hospital. Her mother, Carole Shipsey, provided further social media messages from ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally.